96 related articles for article (PubMed ID: 17716855)
1. Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1592-602. PubMed ID: 17716855
[TBL] [Abstract][Full Text] [Related]
2. Rifampin modulation of xeno- and endobiotic conjugating enzyme mRNA expression and associated microRNAs in human hepatocytes.
Gufford BT; Robarge JD; Eadon MT; Gao H; Lin H; Liu Y; Desta Z; Skaar TC
Pharmacol Res Perspect; 2018 Apr; 6(2):e00386. PubMed ID: 29610665
[TBL] [Abstract][Full Text] [Related]
3. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes.
Guo L; Dial S; Shi L; Branham W; Liu J; Fang JL; Green B; Deng H; Kaput J; Ning B
Drug Metab Dispos; 2011 Mar; 39(3):528-38. PubMed ID: 21149542
[TBL] [Abstract][Full Text] [Related]
4. Metabolic enzyme considerations in cancer therapy.
Jain AK; Jain S; Rana AC
Malays J Med Sci; 2007 Jan; 14(1):10-7. PubMed ID: 22593646
[TBL] [Abstract][Full Text] [Related]
5. Drug metabolism by the human hepatoma cell, Hep G2.
Sassa S; Sugita O; Galbraith RA; Kappas A
Biochem Biophys Res Commun; 1987 Feb; 143(1):52-7. PubMed ID: 3030322
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.
Godoy P; Hewitt NJ; Albrecht U; Andersen ME; Ansari N; Bhattacharya S; Bode JG; Bolleyn J; Borner C; Böttger J; Braeuning A; Budinsky RA; Burkhardt B; Cameron NR; Camussi G; Cho CS; Choi YJ; Craig Rowlands J; Dahmen U; Damm G; Dirsch O; Donato MT; Dong J; Dooley S; Drasdo D; Eakins R; Ferreira KS; Fonsato V; Fraczek J; Gebhardt R; Gibson A; Glanemann M; Goldring CE; Gómez-Lechón MJ; Groothuis GM; Gustavsson L; Guyot C; Hallifax D; Hammad S; Hayward A; Häussinger D; Hellerbrand C; Hewitt P; Hoehme S; Holzhütter HG; Houston JB; Hrach J; Ito K; Jaeschke H; Keitel V; Kelm JM; Kevin Park B; Kordes C; Kullak-Ublick GA; LeCluyse EL; Lu P; Luebke-Wheeler J; Lutz A; Maltman DJ; Matz-Soja M; McMullen P; Merfort I; Messner S; Meyer C; Mwinyi J; Naisbitt DJ; Nussler AK; Olinga P; Pampaloni F; Pi J; Pluta L; Przyborski SA; Ramachandran A; Rogiers V; Rowe C; Schelcher C; Schmich K; Schwarz M; Singh B; Stelzer EH; Stieger B; Stöber R; Sugiyama Y; Tetta C; Thasler WE; Vanhaecke T; Vinken M; Weiss TS; Widera A; Woods CG; Xu JJ; Yarborough KM; Hengstler JG
Arch Toxicol; 2013 Aug; 87(8):1315-530. PubMed ID: 23974980
[TBL] [Abstract][Full Text] [Related]
7. Toxic effects of Arianor Ebony hair dye on human cells.
Tafurt-Cardona Y; Suares-Rocha P; Silva BO; Moraes KCM; Marin-Morales MA
Braz J Med Biol Res; 2023; 56():e12777. PubMed ID: 37493773
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Impact of Physiologically Relevant Oxygen Tensions on Drug Metabolism in 3D Hepatocyte Cultures in Paper Scaffolds.
Sitte ZR; DiProspero TJ; Lockett MR
Curr Protoc; 2023 Feb; 3(2):e662. PubMed ID: 36799572
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of DNA-Damaging Effects Induced by Different Tanning Agents Used in the Processing of Natural Leather-Pilot Study on HepG2 Cell Line.
Ražić SE; Kopjar N; Kašuba V; Skenderi Z; Akalović J; Hrenović J
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296622
[TBL] [Abstract][Full Text] [Related]
10. Investigating the cytotoxic redox mechanism of PFOS within Hep G2 by hyperspectral-assisted scanning electrochemical microscopy.
Goines S; Dick JE
Analyst; 2022 Sep; 147(19):4356-4364. PubMed ID: 36043461
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac-Induced Cytotoxicity in Direct and Indirect Co-Culture of HepG2 Cells with Differentiated THP-1 Cells.
Kawase A; Takashima O; Tanaka S; Shimada H; Iwaki M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955793
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of bilirubin glucuronidation activity in canine and human primary hepatocytes using a 3D culture system.
Omori H; Chikamoto J; Hirano T; Besshi K; Yoshimura N; Hirata M; Otoi T
In Vitro Cell Dev Biol Anim; 2022 Sep; 58(8):712-718. PubMed ID: 35913527
[TBL] [Abstract][Full Text] [Related]
13. Generation of HepG2 Cells with High Expression of Multiple Drug-Metabolizing Enzymes for Drug Discovery Research Using a PITCh System.
Negoro R; Tasaka M; Deguchi S; Takayama K; Fujita T
Cells; 2022 May; 11(10):. PubMed ID: 35626714
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic-pharmacodynamic model based on multi-organ-on-a-chip for drug-drug interaction studies.
Shinha K; Nihei W; Ono T; Nakazato R; Kimura H
Biomicrofluidics; 2020 Jul; 14(4):044108. PubMed ID: 34992705
[TBL] [Abstract][Full Text] [Related]
15. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise.
Arzumanian VA; Kiseleva OI; Poverennaya EV
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884942
[TBL] [Abstract][Full Text] [Related]
16. HepGentox: a novel promising HepG2 reportergene-assay for the detection of genotoxic substances in complex mixtures.
Pinter E; Friedl C; Irnesberger A; Czerny T; Piwonka T; Peñarroya A; Tacker M; Riegel E
PeerJ; 2021; 9():e11883. PubMed ID: 34395098
[TBL] [Abstract][Full Text] [Related]
17. New insights into ethionamide metabolism: influence of oxidized methionine on its degradation path.
Vale N; Duarte D; Correia A; Alves C; Figueiredo P; Santos HA
RSC Med Chem; 2020 Dec; 11(12):1423-1428. PubMed ID: 34095849
[TBL] [Abstract][Full Text] [Related]
18. Physiologically relevant oxygen tensions differentially regulate hepatotoxic responses in HepG2 cells.
DiProspero TJ; Dalrymple E; Lockett MR
Toxicol In Vitro; 2021 Aug; 74():105156. PubMed ID: 33811995
[TBL] [Abstract][Full Text] [Related]
19. A Critical Perspective on 3D Liver Models for Drug Metabolism and Toxicology Studies.
Serras AS; Rodrigues JS; Cipriano M; Rodrigues AV; Oliveira NG; Miranda JP
Front Cell Dev Biol; 2021; 9():626805. PubMed ID: 33732695
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Effects of Newly Synthesized Boron Compounds (BGM and BGD) on Hepatocellular Carcinoma.
Gündüz MK; Bolat M; Kaymak G; Berikten D; Köse DA
Biol Trace Elem Res; 2022 Jan; 200(1):134-146. PubMed ID: 33634364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
